Among them, SRD5A1 and SRD5A2 were reported to be highly expressed in human liver, and the protein level of SRD5A1 increased with the severity of nonalcoholic fatty liver disease (NAFLD) [11]. This evidence concerns the gene SRD5A1 and metabolic dysfunction-associated steatotic liver disease.